Browsing Tag
Velan Capital
1 post
Edesa Biotech raises capital to advance CXCL10 antibody program
Edesa Biotech, Inc. has successfully raised $15 million through a private placement offering, a critical move that will…
Business news, market intelligence, and global industry analysis.